Evaluation of pathophysiology of cancer based on HLA and APRs.

Evaluation of pathophysiology of cancer based on HLA and APRs. - Japan cancer treatment and behavior study group (JCTB study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037478

Enrollment

1000

Registered

2019-07-29

Start date

1990-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer Gastric cancer Colorectal cancer Liver cancer Pancreatic cancer Gallbladder and bili duct cancer Breast cancer Lung cancer

Interventions

Examination of HLA and APR

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Biopsy-proven primary cancer patients who gave informed consent.

Exclusion criteria

Exclusion criteria: not particular

Design outcomes

Primary

Measure	Time frame
The association between HLA and the cancer risk.	—

Secondary

Measure	Time frame
The association between Host factors and the cancer risk.	—

Countries

Japan

Contacts

Public ContactKyoji Ogoshi

Tokai University Department of Surgery

ogoshi@is.icc.u-tokai.ac.jp0463-96-6163

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026